N-甲基-3,3-二苯基丙胺 | 28075-29-8

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-甲基-3,3-二苯基丙胺
• 英文名称: N-methyl-3,3-diphenylpropylamine
• 英文别名: (3,3-diphenyl-1-propyl)(methyl)amine；N-methyl-3,3-diphenylpropan-1-amine；(3,3-diphenylpropyl)-methylamine
• CAS: 28075-29-8
• 化学式: C₁₆H₁₉N
• mdl: MFCD08458400
• 分子量: 225.334
• InChiKey: AKEGHAUFMKCWGX-UHFFFAOYSA-N

物化性质

• 沸点：
  178 °C(Press: 10 Torr)
• 密度：
  0.988±0.06 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090
• 危险性防范说明：
  P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P362,P403+P233,P501
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存于室温、避光且在惰性气体环境下

反应信息

• 作为反应物：
  描述：

  N-甲基-3,3-二苯基丙胺 在 sodium tetrahydroborate 作用下， 以 甲醇 、 乙醚 为溶剂， 反应 0.08h， 生成 4-[N-(3,3-diphenylpropyl)-N-methylamino]-2-butanol
  参考文献：
  名称：

  Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity

  摘要：

  A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenyl-propylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4-dihydropyridines binding site labelled by H-3-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375-lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries. (C) Elsevier, Paris.

  DOI：

  10.1016/s0223-5234(98)80015-9
• 作为产物：
  描述：

  N-甲基苄胺 生成 N-甲基-3,3-二苯基丙胺
  参考文献：
  名称：

  Therapeutically active flavonyl-1,4-dihydrophyridines

  摘要：

  这种具有一般式(I)的新型黄酮基-1,4-二氢吡啶是治疗有效的钙拮抗剂和平滑肌松弛剂。

  公开号：

  US04806534A1

文献信息

• Inhibitors of farnesyl-protein transferase
  申请人：Merck & Co., Inc.

  公开号：US05756528A1

  公开（公告）日：1998-05-26

  The present invention comprises low molecular weight peptidyl compounds that inhibit the farnesyl-protein transferase. Furthermore, these compounds differ from the mono- or dipeptidyl analogs previously described as inhibitors of farnesyl-protein transferase in that they do not have a thiol moiety. The lack of the thiol offers unique advantages in terms of improved pharmacokinetic behavior in animals, prevention of thiol-dependent chemical reactions, such as rapid autoxidation and disulfide formation with endogenous thiols, and reduced systemic toxicity. Further contained in this invention are chemotherapeutic compositions containing these farnesyl transferase inhibitors and methods for their production.

  本发明包括抑制法尼基-蛋白转移酶的低分子量肽类化合物。此外，这些化合物与先前描述的作为法尼基-蛋白转移酶抑制剂的单肽或二肽类似物不同之处在于它们不含硫醇基团。缺乏硫醇基团在动物体内具有改善药代动力学行为、预防硫醇依赖性化学反应（如快速自氧化和与内源硫醇形成二硫键）以及减少全身毒性方面提供了独特优势。本发明还包括含有这些法尼基转移酶抑制剂的化疗组合物以及其生产方法。
• Reactions of Amino Alcohols in Superacid:  The Direct Observation of Dicationic Intermediates and Their Application in Synthesis
  作者：Douglas A. Klumpp、Sharon L. Aguirre、Gregorio V. Sanchez、Sarah J. de Leon

  DOI：10.1021/ol016408y

  日期：2001.8.1

  [reaction: see text]. The chemistry of amino alcohols has been studied in superacidic media, and these compounds have been found to ionize cleanly to the dication intermediates. Several dicationic species have been directly observed by low-temperature 13C NMR, including those from epinephrine (adrenaline) and synephrine. Amino alcohols react (70-99% yields) with C6H6 in triflic acid (CF3SO3H) by electrophilic

  [反应：请参见文字]。氨基醇的化学性质已在超酸性介质中进行了研究，发现这些化合物可清洁地离子化成指示剂中间体。通过低温13 C NMR直接观察到了几种药物，包括肾上腺素（肾上腺素）和肾上腺素的药物。氨基醇通过亲电子芳族取代与三氟甲磺酸（CF3SO3H）中的C6H6反应（产率70-99％）。
• PYRIMIDINE COMPOUND
  申请人：Matsushima Yuji

  公开号：US20110053912A1

  公开（公告）日：2011-03-03

  A novel and excellent method for preventing and/or treating diseases related to a cannabinoid type 2 receptor, based on an agonistic action on a cannabinoid type 2 receptor. It was found that a hetero ring derivative mainly having two substituents, for example, a pyrimidine-5-carboxamide derivative having a substituent amino group at the 2-position, exhibits a potent agonistic action on a cannabinoid type 2 receptor, and can be an agent for preventing and/or treating diseases related to a cannabinoid type 2 receptor such as inflammatory diseases, pain, and the like.

  一种预防和/或治疗与大麻素2型受体相关疾病的新颖优秀方法，基于对大麻素2型受体的激动作用。发现一种异核环衍生物主要具有两个取代基，例如，在2-位置具有取代基氨基的嘧啶-5-羧酰胺衍生物，表现出对大麻素2型受体的强效激动作用，可以成为预防和/或治疗与大麻素2型受体相关疾病，如炎症性疾病、疼痛等的药物。
• Amine derivatives having cardiovascular activity
  申请人：Simes Societa Italiana Medicinali & Sintetici SpA

  公开号：US05047425A1

  公开（公告）日：1991-09-10

  Compounds of the formula ##STR1## wherein Ar, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, X and n have the meanings mentioned in the description, processes and intermediates for their preparation, pharmaceutical compositions which contain them and their use in therapy in the treatment of cardiovascular diseases.

  式为##STR1##的化合物，其中Ar、R、R.sub.1、R.sub.2、R.sub.3、R.sub.4、X和n的含义如描述中所述，它们的制备过程和中间体，含有它们的药物组合物以及它们在治疗心血管疾病中的用途。
• [EN] QUINAZOLINYL-AMINO DERIVATIVES HAVING alpha -ANTAGONIST ACTIVITY<br/>[FR] DERIVES QUINAZOLINYL-AMINO POSSEDANT UNE ACTIVITE CONTRE LES ADRENORECEPTEURS alpha
  申请人：RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY

  公开号：WO1995025726A1

  公开（公告）日：1995-09-28

  (EN) New quinazolinyl-amino derivatives useful as $g(a)1-adrenoreceptors blockers are described. These compounds can be used as therapeutical agents for treating affections and diseases related with the hyperactivity of the $g(a)-adrenergic system, as, for example, arterial hypertension, prostate benign hyperplasia (BHP), high intraocular pressure and hypercholesterolemia. Processes for the preparation of the above said compounds are also described.(FR) L'invention se rapporte à de nouveaux dérivés quinazolinyl-amino utiles en tant qu'agents de blocage des adrénorécepteurs $g(a)1. On peut utiliser ces composés en tant qu'agents thérapeutiques dans le traitement des affections et maladies associées à l'hyperactivité du système $g(a)-adrénergique, comme par exemple l'hypertension artérielle, l'adénome prostatique (BHP), la tension intra-oculaire élevée et l'hypercholestérolémie. L'invention concerne également des procédés de préparation de ces composés.

  (EN) 描述了新的喹唑啉基-氨基衍生物，可用作$g(a)1-肾上腺素受体阻滞剂。这些化合物可用作治疗与$g(a)-肾上腺素能系统的高活性相关的疾病和症状的治疗剂，例如动脉高血压、前列腺良性增生症（BHP）、高眼压和高胆固醇血症。还描述了制备上述化合物的方法。 (FR) 描述了新的喹唑啉基-氨基衍生物，可用作$g(a)1-肾上腺素受体阻滞剂。这些化合物可用作治疗与$g(a)-肾上腺素能系统的高活性相关的疾病和症状的治疗剂，例如动脉高血压、前列腺良性增生症（BHP）、高眼压和高胆固醇血症。还描述了制备上述化合物的方法。